| __timestamp | BioMarin Pharmaceutical Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 3401685 |
| Thursday, January 1, 2015 | 634806000 | 4284228 |
| Friday, January 1, 2016 | 661905000 | 3581295 |
| Sunday, January 1, 2017 | 610753000 | 4838300 |
| Monday, January 1, 2018 | 696328000 | 24891534 |
| Tuesday, January 1, 2019 | 715007000 | 31347891 |
| Wednesday, January 1, 2020 | 628116000 | 17480747 |
| Friday, January 1, 2021 | 628793000 | 34710152 |
| Saturday, January 1, 2022 | 649606000 | 108459978 |
| Sunday, January 1, 2023 | 746773000 | 181563523 |
| Monday, January 1, 2024 | 747184000 | 176326321 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. BioMarin Pharmaceutical Inc. and Opthea Limited, two prominent players in the field, have demonstrated contrasting strategies over the past decade. From 2014 to 2023, BioMarin consistently invested heavily in R&D, with expenditures peaking at approximately $747 million in 2023, reflecting a 62% increase from 2014. This robust investment underscores BioMarin's dedication to advancing its pipeline of therapies.
Conversely, Opthea Limited, while smaller in scale, has shown a remarkable growth trajectory in its R&D spending. From a modest $3.4 million in 2014, Opthea's R&D expenses surged to $182 million by 2023, marking an exponential increase of over 5,200%. This dramatic rise highlights Opthea's strategic pivot towards aggressive research initiatives, positioning itself as a formidable contender in the biotech arena.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Opthea Limited
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: Opthea Limited vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Opthea Limited vs Supernus Pharmaceuticals, Inc.
R&D Insights: How Opthea Limited and Wave Life Sciences Ltd. Allocate Funds